Back to Directory

Ursula Buchholz

Email

ubuchholz@niaid.nih.gov

Phone

Institution

NIAID, NIH

Address

NIAID, NIH
RNA viruses section
Laboratory of Infectious Diseases
NIAID, NIH
Bldg. 50, Rm. 6503
50 South Drive, MSC 8007
Bethesda, MD 20892
United States of America

Request an Update

Affiliated Studies

IMPAACT 2018: Randomized Phase I Study of the Infectivity, Safety, and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV delta NS2/delta 1313/I1314L or RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age

DAIDS Number

38405

Research Area

Complications & Comorbidities

Study Status

Concluded

IMPAACT 2021: Randomized Phase I/II Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV delta NS2/ delta 1313/I1314L, RSV 6120/ delta NS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

DAIDS Number

38530

Research Area

Cure and Immunotherapy

Study Status

Participants Off Study and Primary Analysis Completed

P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine

DAIDS Number

11796

Research Area

Vaccine

Study Status

Concluded

P1114: Safety and Immunogenicity of an RSV Vaccine cps2

DAIDS Number

11948

Research Area

Complications & Comorbidities

Study Status

Concluded

Show All